Remarkably, we found that CD141+ mDCs may also have an important implication in SARS-CoV-2 vaccination immunity, which is one of the cell types that is known to be depleted in COVID-19 patients and which is important for disease progression (55, 59). The gene discussed is THBD; the disease is COVID-19.